Cargando…

Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults

BACKGROUND: Aging is the primary risk factor for cardiovascular diseases, the leading cause of death worldwide. Age-related increases in systolic blood pressure (SBP) link advancing age to cardiovascular disease risk. A key mechanism mediating the increase in SBP with aging is stiffening of the larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freeberg, Kaitlin A., Craighead, Daniel H., Martens, Christopher R., You, Zhiying, Chonchol, Michel, Seals, Douglas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127073/ https://www.ncbi.nlm.nih.gov/pubmed/35620522 http://dx.doi.org/10.3389/fcvm.2022.881703

Ejemplares similares

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults
por: Martens, Christopher R., et al.
Publicado: (2018)

Vascular Endothelial Function in Midlife/Older Adults Classified According to 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines
por: Craighead, Daniel H., et al.
Publicado: (2020)

Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with “standard of care” aerobic exercise
por: Craighead, Daniel H., et al.
Publicado: (2022)

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
por: Vreones, Michael, et al.
Publicado: (2022)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017)

Time‐Efficient Inspiratory Muscle Strength Training Lowers Blood Pressure and Improves Endothelial Function, NO Bioavailability, and Oxidative Stress in Midlife/Older Adults With Above‐Normal Blood Pressure
por: Craighead, Daniel H., et al.
Publicado: (2021)

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022)

Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease
por: Gaare, Johannes J., et al.
Publicado: (2023)

SUPPLEMENTATION WITH NICOTINAMIDE RIBOSIDE ATTENUATES T CELL EXHAUSTION AND IMPROVES SURVIVAL IN SEPSIS
por: Zhao, Guang-ju, et al.
Publicado: (2023)

What is really known about the effects of nicotinamide riboside supplementation in humans
por: Damgaard, Mads V., et al.
Publicado: (2023)

Dihydronicotinamide riboside: synthesis from nicotinamide riboside chloride, purification and stability studies
por: Zarei, Amin, et al.
Publicado: (2021)

Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans
por: Peluso, A. Augusto, et al.
Publicado: (2023)

The Clinical Effects of Nicotinamide Riboside on Inflammatory Parameters
por: Kwon, Jun, et al.
Publicado: (2022)

Emerging Role of Nicotinamide Riboside in Health and Diseases
por: Sharma, Chiranjeev, et al.
Publicado: (2022)

The effects of in ovo nicotinamide riboside dose on broiler myogenesis
por: Xu, Xiaoxing, et al.
Publicado: (2020)

Supplementation with Nicotinamide Riboside Reduces Brain Inflammation and Improves Cognitive Function in Diabetic Mice
por: Lee, Hee Jae, et al.
Publicado: (2019)

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Ratajczak, Joanna, et al.
Publicado: (2016)

Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells
por: Kropotov, Andrey, et al.
Publicado: (2021)

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
por: Trammell, Samuel A. J., et al.
Publicado: (2016)

The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018)

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
por: Mehmel, Mario, et al.
Publicado: (2020)

New Crystalline Salts of Nicotinamide Riboside as Food Additives
por: Schabert, Günter, et al.
Publicado: (2021)

Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
por: Zarei, Amin, et al.
Publicado: (2021)

Nicotinamide Riboside Supports Brain Health: Assessing the Evidence
por: Nkrumah-Elie, Yasmeen, et al.
Publicado: (2022)

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast
por: Orlandi, Ivan, et al.
Publicado: (2020)

Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
por: Schaefer, Patrick M., et al.
Publicado: (2022)

The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
por: Delabie, Willem, et al.
Publicado: (2019)

Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome
por: Williams, Ashley S., et al.
Publicado: (2021)

Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD(+)
por: Tempel, Wolfram, et al.
Publicado: (2007)

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
por: Trammell, Samuel A.J., et al.
Publicado: (2016)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects
por: Podyacheva, Ekaterina, et al.
Publicado: (2021)

Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022)

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
por: Remie, Carlijn M E, et al.
Publicado: (2020)

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
por: Veenhuis, Stefanie J.G., et al.
Publicado: (2021)

In ovo feeding of nicotinamide riboside affects broiler pectoralis major muscle development(,)
por: Gonzalez, John M, et al.
Publicado: (2020)

Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice
por: de Picciotto, Natalie E., et al.
Publicado: (2016)

Cerebrovascular pulsatility index is higher in chronic kidney disease
por: Oh, Ester S., et al.
Publicado: (2023)

Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD(+) without impacting respiratory capacity or insulin sensitivity
por: Damgaard, Mads V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t4gm3k4n93p8aituedbahtpomg